WSG Stock Chart & Stats
€0.22
€0.00(0.00%)
At close: 4:00 PM EDT
€0.22
€0.00(0.00%)
Day’s Range― - ―
52-Week Range€0.14 - €0.29
Previous CloseN/A
Volume0.00
Average Volume (3M)1.00
Market Cap
€710.10M
Enterprise Value€5.96K
Total Cash (Recent Filing)€4.56B
Total Debt (Recent Filing)€1.34B
Price to Earnings (P/E)―
Beta0.35
Next Earnings
Mar 19, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.21
Shares Outstanding5,035,802,000
10 Day Avg. Volume5
30 Day Avg. Volume1
Financial Highlights & Ratios
PEG Ratio0.04
Price to Book (P/B)0.46
Price to Sales (P/S)0.64
P/FCF Ratio4.83
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)>-0.01
Revenue Forecast (FY)€1.42B
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetA conservative balance sheet and declining debt provide financial flexibility while reducing refinancing pressure. This gives the company greater capacity to withstand weaker earnings, support operations, and fund strategic priorities during the next several quarters.
Recent Cash GenerationStrong operating and free cash flow in the latest two years shows that the business is still converting activity into cash despite reduced profitability. If maintained, this can support liquidity, investment, and shareholder returns without relying heavily on additional borrowing.
Broad TCM Product And Channel BaseParticipation across finished medicines, decoction pieces, and related healthcare offerings gives the company multiple ways to serve hospitals, pharmacies, providers, and consumers. This breadth can support market reach and reduce reliance on a single product or sales channel.
Bears Say
Profitability DeteriorationThe shift from sustained profits to near break-even and then a net loss indicates a material weakening in earnings power. Compressed margins reduce internal funding capacity and make future returns more dependent on a successful recovery in operating performance.
Persistent Revenue DeclinesRepeated revenue declines point to inconsistent demand or pricing momentum rather than a steadily expanding business. Continued top-line weakness could limit operating leverage, pressure margins further, and make it harder for the company to restore sustainable profitability.
Volatile Cash-Flow DurabilityRecent positive cash generation is tempered by a history of negative free cash flow and a sharp slowdown in 2025 growth. This volatility raises questions about consistency across the cycle and whether current cash conversion can remain strong alongside the reported loss.
China Traditional Chinese Medicine Holdings Co News
WSG FAQ
What was China Traditional Chinese Medicine Holdings Co Ltd’s price range in the past 12 months?
China Traditional Chinese Medicine Holdings Co Ltd lowest stock price was €0.14 and its highest was €0.29 in the past 12 months.
What is China Traditional Chinese Medicine Holdings Co Ltd’s market cap?
China Traditional Chinese Medicine Holdings Co Ltd’s market cap is €710.10M.
When is China Traditional Chinese Medicine Holdings Co Ltd’s upcoming earnings report date?
China Traditional Chinese Medicine Holdings Co Ltd’s upcoming earnings report date is Mar 19, 2027 which is in 181 days.
How were China Traditional Chinese Medicine Holdings Co Ltd’s earnings last quarter?
China Traditional Chinese Medicine Holdings Co Ltd released its earnings results on Aug 28, 2026. The company reported -€0.02 earnings per share for the quarter.
Is China Traditional Chinese Medicine Holdings Co Ltd overvalued?
According to Wall Street analysts China Traditional Chinese Medicine Holdings Co Ltd’s price is currently Overvalued.
Does China Traditional Chinese Medicine Holdings Co Ltd pay dividends?
China Traditional Chinese Medicine Holdings Co Ltd does not currently pay dividends.
What is China Traditional Chinese Medicine Holdings Co Ltd’s EPS estimate?
China Traditional Chinese Medicine Holdings Co Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does China Traditional Chinese Medicine Holdings Co Ltd have?
China Traditional Chinese Medicine Holdings Co Ltd has 5,035,802,000 shares outstanding.
What happened to China Traditional Chinese Medicine Holdings Co Ltd’s price movement after its last earnings report?
China Traditional Chinese Medicine Holdings Co Ltd reported an EPS of -€0.02 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of China Traditional Chinese Medicine Holdings Co Ltd?
Currently, no hedge funds are holding shares in DE:WSG
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
China Traditional Chinese Medicine Holdings Co Ltd
China Traditional Chinese Medicine Holdings Co. Limited functions as an investment holding company, primarily focusing on the research, development, and sale of traditional Chinese medicine and other pharmaceutical goods across the People's Republic of China. The company's product range includes medicinal granules, finished pharmaceutical preparations, pre-portioned decoction materials, and various healthcare products. Furthermore, its operations extend to the cultivation and management of Chinese medicinal herbs, the manufacturing of traditional Chinese medicines, and the trading of pharmaceutical products. It also delivers marketing, advertising, and consulting services related to TCM, and operates retail outlets for pharmaceuticals and decoction products. Property leasing services represent another facet of its business. The company distributes its products to healthcare facilities and retail pharmacies. Established in 1573 and headquartered in Wan Chai, Hong Kong, the firm was formerly known as China Traditional Chinese Medicine Co. Limited before adopting its current name in July 2016.
Technical Analysis
Guangzhou Baiyunshan Pharmaceutical Holdings Company
―
Wai Yuen Tong Medicine Holdings Limited
―
Grand Pharmaceutical Group Limited
―
Golden Throat Holdings Group Co Ltd
―
Shandong Xinhua Pharmaceutical Company Limited Class H
―